(Q40424204)

20 September 2017

1 reference

title

Clinical use of tacrolimus (FK-506) in infants and children with renal transplants (English)

1 reference

20 September 2017

D. Ellis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577418

19 May 2024

language of work or name

1 reference

1 August 1995

1 reference

full work available at URL

20 September 2017

https://link.springer.com/content/pdf/10.1007/BF00866738.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577418

http://link.springer.com/content/pdf/10.1007/BF00866738.pdf

19 May 2024

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00866738/fulltext.html

19 May 2024

1 reference

http://link.springer.com/content/pdf/10.1007/BF00866738

19 May 2024

1 reference

19 May 2024

1 reference

20 September 2017

volume

9

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

487-494

1 reference

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

20 September 2017

cites work

1 reference

12 December 2020

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.

1 reference

12 December 2020

Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine

1 reference

12 December 2020

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

12 December 2020

Monitoring FK 506 concentrations in plasma and whole blood

1 reference

12 December 2020

Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers

1 reference

12 December 2020

Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?

1 reference

12 December 2020

Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients

1 reference

12 December 2020

New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients

1 reference

12 December 2020

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

1 reference

12 December 2020

Two-year experience with FK 506 in pediatric patients

1 reference

12 December 2020

A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.

1 reference

12 December 2020

Adverse effects associated with the use of FK 506

1 reference

12 December 2020

Immunophilins in protein folding and immunosuppression.

1 reference

12 December 2020

FK 506: monitoring in plasma or in whole blood?

1 reference

12 December 2020

Posttransplant diabetes mellitus--a review.

1 reference

12 December 2020

A highly sensitive method to assay FK-506 levels in plasma

1 reference

12 December 2020

FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication

1 reference

12 December 2020

Tacrolimus, a new immunosuppressant--a review of the literature

1 reference

12 December 2020

Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children

1 reference

12 December 2020

A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression

1 reference

12 December 2020

In vitro FK 506 kidney tubular cell toxicity

1 reference

12 December 2020

A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorder

1 reference

12 December 2020

The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine

1 reference

12 December 2020

The effects of FK 506 on renal function after liver transplantation

1 reference

12 December 2020

Epstein-Barr virus--an old dog with new tricks

1 reference

12 December 2020

Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506

1 reference

12 December 2020

Assay of FK 506 in plasma.

1 reference

12 December 2020

Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis.

1 reference

12 December 2020

Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation

1 reference

12 December 2020

Influence of FK 506 on renal blood flow

1 reference

12 December 2020

Physical growth: National Center for Health Statistics percentiles

1 reference

12 December 2020

Falsely elevated FK-506 levels caused by sampling through central venous catheters

1 reference

12 December 2020

Prevention of cytomegalovirus infection in the pediatric renal transplant recipient

1 reference

12 December 2020

Pediatric intravenous FK506--how much are we really infusing?

1 reference

12 December 2020

FK 506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells and tubular cell toxicity in vitro

1 reference

12 December 2020

The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes

1 reference

12 December 2020

FK506 in pediatric kidney transplantation--primary and rescue experience

1 reference

12 December 2020

A comparison of the renal effects (ERPF, GFR, and FF) of FK 506 and cyclosporine in patients with liver transplantation

1 reference

12 December 2020

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

12 December 2020

Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients

1 reference

12 December 2020

American journal of hospital pharmacy

14

49

119

D Taormina

1992

1 reference

19 May 2024

Identifiers

DOI

10.1007/BF00866738

1 reference

Dimensions Publication ID

20 September 2017

1005068453

0 references

1 reference